Cho Dennis 4

What Happened
Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience (TWST), sold 5,000 shares on February 11, 2026 at $49.93 per share, generating proceeds of approximately $249,650. The Form 4 reports the transaction as a sale (S).

Key Details

• Transaction date and price: Feb 11, 2026 — 5,000 shares at $49.93 each. Total proceeds ≈ $249,650.
• Method: Reported as an open-market or private sale (Form 4 lists "open market or private sale").
• Post-transaction holdings: Not specified in the information provided in this summary.
• Footnote: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Cho on May 7, 2025.
• Filing timing: Form 4 was filed Feb 13, 2026 for the Feb 11 transaction, which appears to be a timely filing under the standard two-business-day requirement.

Context
Sales executed under a 10b5-1 plan are pre-arranged and often reflect a scheduled disposition rather than a contemporaneous view of company prospects. As a sale (not a purchase), this transaction is generally considered routine and does not by itself indicate management sentiment about Twist’s future performance.